(S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS 100306-34-1 Purity: ≥98.0% Dapoxetine Hydrochloride Intermediate Factory High Purity

Chemical Name: (S)-(-)-3-Chloro-1-Phenyl-1-Propanol  CAS: 100306-34-1 Appearance: White Powder Purity: ≥98.0%  Intermediate of Dapoxetine Hydrochloride (CAS: 129938-20-1) in the treatment of Premature Ejaculation in Men (PE) Enquiry: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Commercial Supply Dapoxetine Hydrochloride and Related Intermediates: 3-Chloropropiophenone CAS: 936-59-4 (S)-3-Amino-3-Phenylpropan-1-ol CAS: 82769-76-4 (S)-3-Amino-3-Phenylpropanoic Acid CAS: 40856-44-8 (R)-Diphenylprolinol CAS: 22348-32-9 (S)-Diphenylprolinol CAS: 112068-01-6 (S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-34-1 Dapoxetine Hydrochloride CAS: 129938-20-1
Item Specifications
Appearance White to Almost White Powder
Purity ≥98.0%
Melting Point 54.0℃~58.0℃
Moisture (K.F) ≤0.50%
Test Standard Enterprise Standard
Usage Dapoxetine Hydrochloride (CAS: 129938-20-1) Intermediate 

Description:

Specifications:

Package & Storage:

Chemical Name (S)-(-)-3-Chloro-1-Phenyl-1-Propanol
Synonyms (S)-(-)-α-(2-Chloroethyl)benzyl Alcohol
CAS Number 100306-34-1
CAT Number RF-CC116
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C9H11ClO
Molecular Weight 170.64
Density  1.149
Shipping Condition Shipped Under Ambient Temperature
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-(-)-3-Chloro-1-Phenyl-1-Propanol (CAS: 100306-34-1) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and API synthesis. (S)-(-)-3-Chloro-1-Phenyl-1-Propanol (CAS: 100306-34-1), Intermediate of Dapoxetine Hydrochloride (CAS: 129938-20-1). Dapoxetine Hydrochloride (CAS: 129938-20-1) is a short-acting novel selective serotonin reuptake inhibitor marketed for the treatment of premature ejaculation in men. Premature ejaculation (PE) is the most common male sexual disorder, estimated to affect up to 30% of men.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours